

![]() |
β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial |
|
Authors | ![]() | |
Published in | JAMA internal medicine. 2014, vol. 174, no. 12, p. 1894-1901 | |
Abstract | The clinical benefit of adding a macrolide to a β-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial. | |
Identifiers | PMID: 25286173 | |
Full text | ||
Structures | ||
Research groups | Acquisition de l'expertise médicale (662) Epidémiologie clinique (115) Epidémiologie et contrôle de la résistance aux antibiotiques (866) Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) (585) Prévention du cancer du col utérin (933) | |
Citation (ISO format) | GARIN, Nicolas et al. β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. In: JAMA internal medicine, 2014, vol. 174, n° 12, p. 1894-1901. doi: 10.1001/jamainternmed.2014.4887 https://archive-ouverte.unige.ch/unige:43659 |